160 related articles for article (PubMed ID: 12034029)
1. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
[TBL] [Abstract][Full Text] [Related]
2. The carboxyterminal domains of human IFN-alpha2 and IFN-alpha8 are antigenically homologous.
Vancová I; Kontseková E; Mucha V; Kontsek P
J Interferon Cytokine Res; 2000 May; 20(5):455-61. PubMed ID: 10841073
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.
Overall ML; Hertzog PJ
Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957
[TBL] [Abstract][Full Text] [Related]
4. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
5. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
[TBL] [Abstract][Full Text] [Related]
6. Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN.
Hu R; Bekisz J; Hayes M; Audet S; Beeler J; Petricoin E; Zoon K
J Immunol; 1999 Jul; 163(2):854-60. PubMed ID: 10395679
[TBL] [Abstract][Full Text] [Related]
7. Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag.
Schmeisser H; Kontsek P; Esposito D; Gillette W; Schreiber G; Zoon KC
J Interferon Cytokine Res; 2006 Dec; 26(12):866-76. PubMed ID: 17238829
[TBL] [Abstract][Full Text] [Related]
8. N-terminal amino acids of bovine alpha interferons are relevant for the neutralization of their antiviral activity.
Barreto Filho JB; Eiras PR; Golgher RR
Braz J Med Biol Res; 2001 May; 34(5):663-7. PubMed ID: 11323754
[TBL] [Abstract][Full Text] [Related]
9. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I; Krchnák V
J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
[TBL] [Abstract][Full Text] [Related]
10. Relativity of an antigenic homology between human interferon-alpha 1 and interferon-alpha 2c.
Csabayová M; Kontseková E; Kontsek P
Immunol Invest; 1995 Aug; 24(5):787-93. PubMed ID: 8543342
[TBL] [Abstract][Full Text] [Related]
11. Structure-function analysis of human IFN-alpha. Mapping of a conformational epitope by homologue scanning.
Wang L; Hertzog PJ; Galanis M; Overall ML; Waine GJ; Linnane AW
J Immunol; 1994 Jan; 152(2):705-15. PubMed ID: 7506733
[TBL] [Abstract][Full Text] [Related]
12. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
13. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical mapping of alpha-2 interferon.
Lydon NB; Favre C; Bove S; Neyret O; Benureau S; Levine AM; Seelig GF; Nagabhushan TL; Trotta PP
Biochemistry; 1985 Jul; 24(15):4131-41. PubMed ID: 2413884
[TBL] [Abstract][Full Text] [Related]
15. Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
Viscomi GC; Antonelli G; Bruno C; Scapol L; Malavasi F; Funaro A; Simeoni E; Pestka S; De Pisa F; Dianzani F
J Interferon Cytokine Res; 1999 Apr; 19(4):319-26. PubMed ID: 10334382
[TBL] [Abstract][Full Text] [Related]
16. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
17. Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity.
Shorts LH; Dancz CE; Shupp JW; Pontzer CH
Exp Biol Med (Maywood); 2004 Feb; 229(2):194-202. PubMed ID: 14734798
[TBL] [Abstract][Full Text] [Related]
18. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
Adolf GR
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
[TBL] [Abstract][Full Text] [Related]
19. Protein engineering of interferon alphas.
Hu R; Lei KJ; Bekisz J; Zoon KC
Methods Mol Med; 2005; 116():69-80. PubMed ID: 16000855
[TBL] [Abstract][Full Text] [Related]
20. Immunodominant structures in the aminoterminal portion of human interferon alpha 1.
Kontsek P; Borecký L; Kontseková E; Kolcunová A; Novák M; Zav'yalov VP; Maiorov VA
Mol Immunol; 1992; 29(7-8):863-70. PubMed ID: 1378930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
